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ABSTRACT  10 
Salt sensitivity is an independent CVD and mortality risk factor, present in both hypertensive and 11 
normotensive populations. It is genetically determined and it may affect the relationship between 12 
salt taste perception and salt intake. The aim of this study was to explore the genetic predisposition 13 
to salt sensitivity in young and a middle-aged adult population and its effects on salt taste 14 
perception and salt intake. The effects of sodium loading on blood pressure (BP) were investigated 15 
in 20 normotensive subjects and salt sensitivity defined as the change in BP after seven days of low 16 
sodium (51.3 mmol sodium/day) and seven days of high sodium diet (307.8 mmol sodium/day). 17 
Salt taste perception was identified using the British Standards Institution sensory analysis method 18 
(BS ISO 3972:2011). Salt intake was assessed with a validated FFQ. DNA was genotyped for SNPs 19 
in the SLC4A5, SCNN1B and TRPV1 genes. The subjects with AA genotype of the SLC4A5 20 
rs7571842 exhibited the highest increase in BP (∆SBP=7.75 mmHg, p=0.002, d=2.4; ∆DBP=6.25 21 
mmHg, p=0.044, d=1.3; ∆MAP=6.5 mmHg, p=0.014, d=1.7). The SLC4A5 rs10177833 was 22 
associated with salt intake (p=0.037) and there was an association between salt taste perception and 23 
salt sensitivity (rs=0.551, p=0.041). The association between salt taste perception and discretionary 24 
salt use may depend on the SLC4A5 and TRPV1 genotype. In conclusion, there is a genetic 25 
predisposition to salt sensitivity and it is associated with salt taste perception. The association 26 
between salt taste perception and discretionary salt use suggests that preference for salty taste may 27 
be a driver of salt intake in healthy population and warrants further investigation. 28 
Keywords: blood pressure, genetics, salt sensitivity, salt intake, taste 29 
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1. Introduction 30 
Hypertension is a major cause of CVD and overall mortality (1).  High dietary sodium intake 31 
is a major risk factor for hypertension (2,3) estimated to be responsible for one in 10 deaths from 32 
CVD events (4). In 2010, the estimated mean global sodium consumption was 3.95 g per day, with 33 
regional mean levels ranging from 2.18 g to 5.51 g/day, exceeding the reference intake of 2.0 g of 34 
sodium/day (4,5). 35 
One of the main determinants of food intake, and potentially salt, is taste (6). The ability to 36 
perceive a certain taste may be genetically determined (7). More specifically, genetic variation in 37 
taste receptors may alter an individual’s taste function (8). However, to our knowledge, only one 38 
study reports the genetic predisposition to salt taste in humans. SNPs in genes coding for ion 39 
channels, the epithelial sodium channel (SCNN1B) rs239345 and the transient receptor potential 40 
cation subfamily V member 1 channel (TRPV1) rs8065080, modified the salt taste perception in 95 41 
white young adults (8). The effect of these genetic variants on actual sodium intake has not been 42 
investigated and the results warrant further investigation. In addition, a link between salt taste 43 
perception and blood pressure (BP) is suggested. A number of studies reported that individuals with 44 
lower ability to taste salt (i.e. reduced salt taste sensitivity) exhibited higher BP compared to 45 
individuals with enhanced ability to perceive salty taste. This was observed both in adults and 46 
children and across different populations (9-12). Moreover, research suggests an association between 47 
salt taste sensitivity and salt intake, albeit inconclusive (13,14). Considering the above and with the 48 
notion that high salt intake is a major risk factor for raised BP (2,3), it can be hypothesised that 49 
reduced salt taste sensitivity would result in higher dietary salt intake and consequently in higher 50 
BP.  51 
Furthermore, the mechanisms behind the possible link between salt taste perception and salt 52 
intake are unclear and confounded by other metabolic and physiological aspects of salt metabolism. 53 
The main confounder is salt sensitivity which is defined as an increase in BP in response to a high 54 
dietary salt intake (15). Considering that some individuals do not exhibit such increase, the 55 
distinction is made between salt-sensitive and salt-resistant populations (16). Salt sensitivity displays 56 
a strong heritable component and the genes involved in sodium transport across the cell membrane 57 
have shown a strong effect on salt-sensitive changes in BP (17,18). Specifically, rs7571842 and 58 
rs10177833 in the SLC4A5 gene, coding for electrogenic sodium bicarbonate cotransporter 2, have 59 
been associated with salt sensitivity in Caucasian hypertensive and normotensive populations (19). In 60 
addition to salt taste perception, the TRPV1 gene has been associated with salt sensitivity in 61 
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animals(20,21).  Wang and Wang(20) have reported that in Dahl salt-sensitive rats on a high-salt diet, 62 
TRPV1 expression and function is impaired rendering these rats sensitive to salt load in terms of BP 63 
regulation. Furthermore, the TRPV1 rs8065080 is a missense SNP resulting in amino acid change at 64 
position 585, from isoleucine to valine, potentially affecting protein function (22). Cantero-Recasens 65 
et al. (23) have tested its functional effect by expressing it in HeLa cells and showed a decreased 66 
channel activity in response to two typical TRPV1 stimuli, heat and capsaicin, in TRPV1-Val-585 67 
cells compared to TRPV1-Ile-585. The loss of function effect of the rs8065080, together with 68 
reduced expression and activity of the TRPV1 reported in salt-sensitive animals suggests this 69 
variant may also be involved in salt sensitivity in humans. Finally, several common variants of the 70 
epithelial sodium channel SCNN1B gene, including the rs239345, have been associated with BP or 71 
hypertension in different populations (24,25). 72 
Recent research in animals suggests an association between salt taste perception and salt-73 
sensitive hypertension mediated by the renin-angiotensin aldosterone system (RAAS) dysfunction 74 
(26). To the best of our knowledge, there are no studies in humans confirming this association. In 75 
addition, there are no studies comprehensively exploring the link between salt sensitivity of BP, salt 76 
taste perception and intake. Furthermore, salt sensitivity is present in 51% of hypertensive and 26% 77 
of normotensive populations and it is an independent cardiovascular and mortality risk factor (27,28). 78 
Since reduction in salt intake may lead to significant reductions in BP in susceptible individuals (1,2), 79 
detecting salt sensitivity in young and healthy individuals may result in more successful prevention 80 
of hypertension and consequently CVD (29).  81 
Considering the potential link between salt sensitivity, salt taste perception and dietary salt 82 
intake together with the underlying genetic basis, the aim of this study was to explore the genetic 83 
predisposition to salt sensitivity, expressed as the BP response to sodium loading, in a healthy adult 84 
population and its effects on salt taste perception and dietary salt intake.  85 
 86 
2. Methods 87 
2.1. Subjects 88 
The subjects were predominantly young Caucasians, eight males and 12 females. Subjects 89 
were recruited through advertisements, internet postings and the institutional Centre for Workplace 90 
and Community Health. Eligibility criteria were clearly stated. More specifically, subjects were 91 
excluded with current stage-2 hypertension (systolic blood pressure (SBP) ≥160 mm Hg and/or 92 
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diastolic blood pressure (DBP) ≥100 mm Hg), current or recent (less than one month prior to 93 
screening visit) use of anti-hypertensive medications or medications that affect BP. Further, those 94 
with secondary hypertension, history of CVD, chronic kidney failure, current diabetes were 95 
excluded. Also excluded were individuals with peptic ulcer disease or liver disease requiring 96 
treatment during the previous two years. In addition, pregnant women, underweight (BMI <18.5 97 
kg/m2) and obese (BMI>30 kg/m2) individuals, individuals exceeding maximal recommended 98 
alcohol intake for the UK, those currently adhering to a low sodium diet, or with an illness that 99 
permanently alters taste were also excluded from the study.  100 
All 20 subjects completed the taste threshold determination test to assess salt taste 101 
perception, FFQ and provided a saliva sample. Out of 20 subjects, 19 completed the low- and high 102 
sodium dietary protocols, however, five subjects were excluded due to incomplete 24-hour BP or 103 
urinary excretion data (Figure 1).  104 
This study was conducted according to the guidelines laid down in the Declaration of 105 
Helsinki and all procedures involving human subjects were approved by the Institutional Ethics 106 
Committee. Written informed consent was obtained from each subject before the baseline data 107 
collection informing they can withdraw from the study at any point. The study is registered under 108 
Research Registry unique identification number: researchregistry1652.   109 
 110 
2.2. Baseline measurements 111 
Height and baseline BP and weight were measured during the first examination. Subjects 112 
were instructed to avoid alcohol, cigarette smoking, coffee/tea, and exercise for at least 30 minutes 113 
prior to their BP measurement. Seated BP was measured with an automated BP monitor (OMRON 114 
M24/7, Milton Keynes) using an appropriate size cuff after five minutes of rest. Two measurements 115 
were performed within five minute intervals and used for the analysis and calculation of the mean 116 
baseline SBP and DBP. In addition, demographic data (age, sex and race) was collected and 117 
assessed together with smoking habits and health status information. Physical activity was assessed 118 
with the General Practice Physical Activity Questionnaire. Participants were considered as: active, 119 
moderately active, moderately inactive or inactive (30). 120 
 121 
 122 
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2.3. Taste thresholds for salt 123 
Identification of taste thresholds for salt (salt taste perception) was determined using the 124 
British Standard BS ISO3972:2011 methodology.  Salt taste detection and recognition thresholds 125 
were determined using eight graded sodium chloride solutions (4 mmol/l, 6 mmol/l, 8 mmol/l, 12 126 
mmol/l, 17 mmol/l, 24 mmol/l, 34 mmol/l and 49 mmol/l). Solutions were prepared by dissolving 127 
food grade sodium chloride in spring water. All solutions were prepared on the day of the testing. 128 
Subjects were presented with a sample of each solution by order of increasing concentration starting 129 
with the lowest concentration of 4 mmol/l. The procedure was repeated three times. Three 130 
additional vessels containing dilutions of the same concentration as the preceding vessel were 131 
presented randomly within the sample series. The salt taste detection threshold (STDT) was 132 
identified as the lowest concentration of the sample where the subject can consistently perceive an 133 
impression but not identify the taste. The salt taste recognition threshold (STRT) was identified as 134 
the sample concentration where the subject consistently perceives the taste as salt (31).  135 
 136 
2.4. Habitual dietary salt intake 137 
Baseline energy and dietary salt intake were assessed using a semi-structured validated FFQ. 138 
The questionnaires were analysed using the open source, cross-platform tool FETA (32) and 139 
information on 46 nutrients, including sodium, was obtained. Habitual dietary sodium intake was 140 
energy adjusted and expressed as mg of sodium per 1000 kcal. Information on the frequency of 141 
discretionary salt use was also obtained. Subjects recorded the frequency of adding salt while 142 
cooking and at the table by choosing one of the following: 1) never, 2) rarely, 3) sometimes, 4) 143 
usually and 5) always. 144 
 145 
2.5. Dietary sodium intervention 146 
Study subjects received a low-sodium diet (3 grams of salt or 51.3 mmol of sodium/day) for 147 
seven days, followed by a high-sodium diet (18 grams of salt or 307.8 mmol of sodium/day) for an 148 
additional seven days. Minimal wash-out period between the diets was seven days. The low sodium 149 
diet was designed by investigators using the nutritional analysis software (Nutritics, Nutritics LTD, 150 
Dublin, Ireland). Three meals and two snacks were designed to provide a total of 3 grams of salt per 151 
day and recommended macronutrient intake (33). Total energy intake was determined based on 152 
individual requirements of each subject. Subjects were provided with detailed written instructions 153 
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about the diets and they were also instructed to maintain their coffee, smoking and physical activity 154 
levels. The high sodium diet was formulated by supplementing the low-sodium diet with additional 155 
256.5 mmol of sodium/day (15g of salt per day) dispensed by research staff in small paper sachets 156 
each containing 1g salt (NaCl). To monitor subject compliance with the diets, on the last day of 157 
each period, 24-hour urine was collected for sodium, potassium and creatinine excretion 158 
measurements. During the same period, 24-hour BP measurements were performed with the 24-159 
hour ambulatory BP monitoring device (ABPM).  160 
 161 
2.6. Twenty-four-hour automated BP monitoring 162 
Twenty-four–hour ABPM was attached to the upper, non-dominant arm and BP was 163 
registered at 30-minute intervals during daytime and 60-minute intervals at night time. Data from 164 
the ABPM was downloaded using BP Tracker Software and mean SBP and DBP were calculated. 165 
Subject data with less than 30 successful measurements on each occasion was excluded from the 166 
analysis for salt sensitivity (34). Pulse pressure (PP) was calculated according to the formula: PP = 167 
SBP – DBP and mean arterial pressure (MAP) as: MAP = DBP + 1/3 PP. Salt sensitivity was 168 
defined as an increase of  ≥ 3 mmHg in MAP when transitioning from the low to high sodium diet, 169 
as suggested by Kurtz et al. (35). The change in BP between the high sodium and low sodium diet 170 
(ΔBP) was calculated as:  ΔBP = high sodium diet BP – low sodium diet BP.  171 
 172 
2.7. Biochemical measurements 173 
The 24-hour urinary sodium and potassium were analysed using an automated clinical 174 
chemistry analyser (Randox: Rx Daytona), with intra-assay CV < 6%. Estimated salt intake was 175 
calculated using the equation 17.1 mmol of sodium = 1g of salt. Assessment of the completeness of 176 
the collection was assessed by measuring creatinine levels from the same urine samples. The 177 
following criteria were used: 1) incomplete urine = <0.7 of [mmol urinary creatinine x 113]/[21 x 178 
kilograms of body weight] (36), 2) urinary creatinine <4 mmol/day for women, or <6 mmol/day for 179 
men, or a 24 h urine collection of <500 mL for either sex and extreme outliers for urinary creatinine 180 
(ie, >3 SD from the mean) considered as unacceptable (37). Subjects with incomplete urine 181 
collection from any of the dietary intervention periods, based on any of the two criteria, were 182 
excluded from the analysis.  183 
 184 
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2.8. Single nucleotide polymorphism (SNP) determination 185 
Following the extensive literature review, four SNPs were selected for genotyping:  186 
rs7571842 (A/G) and rs10177833 (A/C) in the SLC4A5 gene, rs239345 (T/A) in the SCNN1B and 187 
rs8065080 (T/C) in the TRPV1 gene. These SNPs were chosen based on their previously reported 188 
associations with BP phenotypes, such as hypertension or salt sensitivity, and salt taste perception. 189 
This was combined with prevalence data (minor allele frequencies) for the SNP (8,19,38) 190 
(Supplementary Table 1). 191 
  At baseline examination a 2 ml saliva sample was collected into a collection vial 192 
(SalivaGene collection module II, STRATEC Molecular, Berlin). A stabiliser provided by the 193 
manufacturer was added to the saliva sample and it was stored at -20 °C until DNA was extracted. 194 
Genomic DNA was extracted using a commercial kit PSP® SalivaGene 17 DNA Kit 1011 195 
(STRATEC Molecular, Berlin) in accordance with the manufacturer protocol. Quality and quantity 196 
were assessed using Nanodrop (ThermoFisher, Waltham, MA, USA). Genotyping was performed 197 
using a pre-designed TaqMan® SNP genotyping assays for the SNPs: rs7571842, rs10177833, 198 
rs239345, rs8065080 and the StepOnePlus thermocycler (Applied Biosystems, CA, USA) with two 199 
technical replicates for each sample. The primers and the probes were pre-designed by Applied 200 
Biosystems with the following codes (C____197439_10, C___1137534_10, C___2387896_30, 201 
C__11679656_10). The PCR amplification was performed under the conditions specified by the 202 
manufacturer. SNPs were accepted when the quality threshold was above 98%. All SNPs had minor 203 
allele frequencies higher than or equal to 30% and these reflected the ones reported in European 204 
populations (38) (Supplementary Table 2).  205 
 206 
2.9. Statistical analysis 207 
Sample size calculation was based on the 4 mmHg difference in MAP when transitioning 208 
from low to high sodium diet. This difference in BP was observed in other studies investigating salt 209 
sensitivity in normotensive populations and with a 24-hour ABPM (39,40). A sample size of 15 was 210 
calculated using an alpha of 0.05, power of 80%, expected large effect size (d=0.8) and a standard 211 
deviation of 5 mmHg. This standard deviation was chosen due to lower variability of BP reported in 212 
younger and healthy individuals (40,41).  213 
All continuous variables are presented as mean and SEM or median (interquartile range). 214 
Categorical variables are presented as absolute (relative) frequencies. Before further statistical 215 
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analysis, continuous variables were tested for normality with the Shapiro-Wilk test. Differences in 216 
baseline characteristics by salt sensitivity status were assessed using an independent samples t-test 217 
(with Levene’s test for equality of variance) or Fischer’s exact test. The difference between clinical 218 
characteristics of subjects between the low and high sodium diets was assessed using paired 219 
samples t-test. An independent samples t-test (with Levene’s test for equality of variance) or Mann-220 
Whitney U test, as appropriate, was used to test for the difference in salt-sensitive changes in BP 221 
and dietary sodium intake by genotypes of interest.  The model used for the analysis was: major 222 
allele homozygote versus heterozygote plus minor allele homozygote. A Cochran Armitage test of 223 
trend was run to determine whether a linear trend exists between the genotypes of interest and the 224 
proportion of subjects with low and high STDT and STRT as well as the proportion of subjects in 225 
different tertiles of energy adjusted sodium intake. Considering there is no universal cut-off point 226 
provided to distinguish between the subjects with low and high salt taste thresholds, a median was 227 
used as a cut-off. Subjects with STDT ≤ 8 mmol/l and STRT ≤12 mmol/l were considered to have 228 
low thresholds.  229 
To assess the relationship between salt taste thresholds and salt-sensitive changes in BP and 230 
salt taste thresholds and sodium intake, Spearman’s correlation analysis was performed. Analyses 231 
were performed using the SPSS software package (version 22.0, Chicago, IL, USA). All tests were 232 
two-tailed, with p < 0.05 considered statistically significant.  233 
 234 
3. Results 235 
3.1. Subject characteristics and compliance with the dietary sodium intervention 236 
 Twenty subjects completed the baseline examination, taste threshold determination test and 237 
FFQ. Of these, 14 subjects provided complete 24-hour ABPM and 24-hour urine excretion data and 238 
were included in the analysis on salt sensitivity of BP. Five subjects were considered salt-sensitive 239 
using the criteria of ≥ 3 mmHg increase in MAP when transitioning from low to high sodium diet. 240 
The study population was normotensive, predominantly white, physically active and non-smoking 241 
with a median age of 28 years (Table 1). There was no significant difference in any of the baseline 242 
parameters between salt-sensitive and salt-resistant subjects.  243 
 In addition, there was no difference in BP between the low sodium and high sodium diet 244 
periods (Table 2). Urinary sodium excretion results demonstrated good compliance with the diet 245 
(p<0.0005) whereas potassium intake remained similar on both diets (p=0.243). 246 
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3.2. Genetic predisposition to salt sensitivity of BP, altered salt taste perception and salt 247 
intake 248 
 Regarding the genetic predisposition to salt sensitivity, the mean change in BP between the 249 
low and high sodium diet differed according to SLC4A5 rs7571842 genotype (Figure 2). The 250 
subjects with AA genotype had the highest increase in BP (∆SBP=7.75 ± 1.44 mmHg, p=0.002, 251 
d=2.4; ∆DBP=6.25 ± 2.81 mmHg, p=0.044, d=1.3; ∆MAP=6.5 ± 2.10 mmHg, p=0.014, d=1.7). 252 
SNPs rs10177833 (SLC4A5) (Figure 2), rs239345 (SCNN1B) and rs8065080 (TRPV1) had no 253 
statistically significant effects on the BP response to dietary sodium manipulation (data not shown). 254 
Moreover, the analysis was conducted to test for the possible difference in the prevalence of males 255 
and females, BMI and age, between the rs7571842 genotype groups. There was no difference in any 256 
of the variables between the AA and AG + GG group (p=1.000, p=0.846 and p=0.584 for sex, BMI 257 
and age respectively). 258 
In contrast with the above described, the proportion of study subjects with low and high salt 259 
taste recognition thresholds was similar according to genotypes of interest (Figure 3). The results of 260 
a Cochrane Armitage test of trend between the different genotype groups (homozygous major allele, 261 
heterozygous and homozygous minor allele) and the proportion of subjects with low and high 262 
STRT were: rs7571842 (p=0.905), rs10177833 (p=0.714), rs239345 (p=0.456), rs8065080 263 
(p=0.078). Similar were observed for STDT (data not shown). However, a linear trend was 264 
observed regarding the distribution of subjects in the first or second + third tertile of energy 265 
adjusted sodium intake according to the SLC4A5 rs10177833. With the increasing number of A 266 
alleles, sodium intake increased (p=0.037, Figure 4). The mean age and BMI as well as the 267 
distribution of sex did not differ between the rs10177833 genotype groups (p=0.129, p=0.551, 268 
p=1.000 for age, BMI and sex respectively). 269 
 270 
3.3. Associations between salt sensitivity of BP, salt taste perception and salt intake 271 
 When exploring the associations between the main outcome variables, there was no 272 
correlation between the mean change in SBP, DBP and MAP, when transitioning from a low to 273 
high sodium diet, and salt taste thresholds (Table 3). However, a positive moderate correlation was 274 
observed between the mean change in PP and STDT (rs=0.551, p=0.041). Sub-group analysis 275 
revealed a strong positive correlation between the change in PP and STDT in the SLC4A5 276 
rs7571842 AG + GG group (rs=0.845, p=0.002).  Similar was observed for the rs10177833. There 277 
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was a strong positive correlation between the change in PP and STDT in the AC + CC group 278 
(rs=0.781, p=0.022, Supplementary Table 3). 279 
Furthermore, in the total study population, the correlation between the STDT and energy-280 
adjusted sodium intake was not significant (rs=0.069, p=0.774). Similar was observed for STRT 281 
(rs=0.025, p=0.918). In addition, the correlation between adding salt while cooking and at the table 282 
and salt taste thresholds was also investigated. No significant correlation was observed (STDT: 283 
rs=0.134, p=0.573 for adding salt at the table and rs=0.342, p=0.140 for adding salt while cooking; 284 
STRT:  rs=0.083, p=0.727 for adding salt at the table and rs= - 0.071, p=0.767 for adding salt while 285 
cooking, Supplementary Table 4). However, as shown in Figure 5, when stratifying according to 286 
genotype, in the AA group of the SLC4A5 rs7571842, a strong and positive correlation was 287 
observed between adding salt while cooking and both STDT (rs=0.868, p=0.011) and STRT 288 
(rs=0.868, p=0.011). In addition, in the TT group of the TRPV1 rs8065080, a moderate and negative 289 
correlation was observed between adding salt at the table and salt taste recognition threshold (rs=-290 
0.636, p=0.048).  291 
  292 
4. Discussion 293 
4.1. Genetics of the BP response to sodium loading, salt taste perception and salt intake  294 
Findings from the present study suggest a genetic predisposition to salt sensitivity in the 295 
study population. Despite the small sample size, salt-sensitive increase in BP was detected. 296 
Moreover, other studies with similar sample sizes, 14-16 subjects respectively, have successfully 297 
investigated and detected this phenomenon in normotensive populations (42-44). Finally, urinary 298 
markers of compliance with the diets, sodium and potassium, were satisfactory showing an overall 299 
good compliance with the diets.   300 
SLC4A5 gene, coding for a sodium hydrogen bicarbonate transporter involved in sodium 301 
transport across the cellular membrane (45), affected salt-sensitive changes in BP. Carey et al. (19) 302 
noted that SNPs rs7571842 and rs10177833 had the most pronounced effects on salt sensitivity. 303 
One of these SNPs, rs7571842, had the greatest effect in this study population, increasing BP in 304 
individuals with AA genotype and confirming the protective effect of the G allele (19).  A post hoc 305 
power calculation revealed that, with the two-tailed 0.05 significance level, this test had a power of 306 
92% to detect a difference in SBP between the two SLC4A5 rs7571842 genotype groups (mean 307 
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values for ΔSBP 7.75 mmHg vs. 0.00 mmHg and standard deviations 2.87 mmHg vs. 1.06 mmHg). 308 
Regarding the rs10177833, the lack of confirmation of its effect may be due to its lower effect size 309 
that could potentially be detected in a larger sample size study. These results, however, align with 310 
Carey et al. (19) where the effect of rs10177833 on salt sensitivity observed in the University of 311 
Virginia (UVA) discovery cohort was not replicated in a HyperPATH study population. Other 312 
SNPs investigated in the present study were not associated with salt sensitivity in previous studies 313 
conducted in humans. The SCNN1B SNPs were associated with hypertension(24,25) but not salt 314 
sensitivity per se suggesting rs239345 may not have an effect on this specific phenotype in healthy 315 
population. Finally, the TRPV1 rs8065080 appears to be functional and is associated with lower 316 
channel activity, a trait observed in salt-sensitive rats (20,23). In this population, it did not have an 317 
effect on salt-sensitive changes in BP, suggesting that other variants in this gene may have more 318 
pronounced effects on BP.  319 
Nevertheless, the A allele of the SLC4A5 rs7571842 is present in approximately half of the 320 
European descent population with a third of the population having the risky AA genotype (38). 321 
Additionally, salt-sensitive rise in BP, following a high sodium diet, was expressed as a continuous 322 
variable. The risk of CVD increases continuously and with each 2 mmHg increase in SBP there is a 323 
7% increase in risk of mortality from IHD and a 10% increase in the risk of mortality from stroke 324 
(46). The increase in SBP in healthy subjects with the rs7571842 AA genotype was 7.75 mmHg, 325 
which emphasises the clinical relevance of these results. Moreover, it has been estimated that 326 
approximately a third of deaths attributed to BP occur in individuals with BP lower than the 327 
hypertensive range (47). They may represent a salt-sensitive part of the population which reflects salt 328 
sensitivity prevalence of 36% in this study. Considering the discrepancies in methods used in 329 
previous studies, it is difficult to draw any conclusion whether this prevalence could be expected in 330 
other populations with similar characteristics. Salt sensitivity prevalence of 26% in normotensives 331 
was established using an intravenous protocol for diagnosis of salt sensitivity (27). However, more 332 
recent work suggests that this method can lead to misclassification and incorrect diagnosis (39,40). 333 
Another potential issue in comparison of different study results is the BP measurement. While most 334 
studies still use the conventional measurements, from the studies that employ 24-hour BP 335 
measurements only a limited number is investigating salt sensitivity solely in healthy, normotensive 336 
populations (48-50).  337 
It should be noted, however, that this study primarily investigated the effects of sodium 338 
loading on BP and as such, the above-described salt sensitivity prevalence should be regarded with 339 
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caution. When identifying subjects as salt-sensitive or salt-resistant it is recommended that the low 340 
and high sodium diets should be administered in a random order to achieve maximal reproducibility 341 
(35). When a low sodium period precedes high sodium period RAAS may not be uniformly 342 
suppressed (51). This may result in an increased BP response on a low sodium diet and would require 343 
larger sample size compared to the one in this study to detect the true effect of dietary sodium 344 
manipulation on BP and estimate the salt sensitivity prevalence. Therefore, if the order of the diets 345 
was randomised and high sodium diet preceded the low sodium diet in a proportion of the study 346 
population, the RAAS may have been supressed to an extent where more uniformity in the BP 347 
response to dietary intervention may have been observed. This in turn, may have resulted in a 348 
statistically significant difference in BP when transitioning from the low to the high sodium diet in 349 
the total study population.  350 
Besides observed genetic predisposition to salt sensitivity of BP, the SLC4A5 rs10177833 351 
was associated with salt intake. With increasing number of A alleles there was a trend towards an 352 
increased energy adjusted sodium intake. The highest proportion of subjects in the second and third 353 
tertile of energy adjusted sodium intake was in the AA genotype group with the majority of these 354 
subjects (85%) having absolute sodium intake above the recommendations (5,52). Recently, Smith et 355 
al. (53) have reported how individuals with enhanced bitter taste perception genotype (GC and GG 356 
alleles for the bitter taste receptor gene TAS2R38) were significantly more likely than CC 357 
homozygotes to have daily sodium intake higher than recommended. Furthermore, Kho et al. (54), in 358 
their genome wide association study (GWAS) have reported on several variants associated with salt 359 
intake. These variants were in genes coding for sodium, potassium and calcium channels, 360 
suggesting that genes coding for sodium transport proteins may be associated with increased salt 361 
intake, similar to the findings of this study. The mechanism behind this association is to be 362 
explored. It is not to exclude the potential expression of this cotransporter in taste receptor cells, as 363 
other sodium-dependent transporters primarily expressed in other tissues have been localised in 364 
tongue (55,56). However, impaired sodium metabolism was reported as a consequence of rs10177833 365 
induced increase in the SLC4A5 transcription under conditions of high sodium intake (57). 366 
Considering its strong linkage disequilibrium (LD) with rs7571842 (19), these two SNPs are most 367 
likely inherited together making the carriers of this genotype at increased risk of developing 368 
hypertension and CVD. 369 
Moreover, there was no genetic predisposition to altered salt taste perception. The 370 
discrepancy in the results of the present study and the one by Dias et al. (8) may be explained by the 371 
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difference in thresholds measured. The taste quality of salt stimulus can be concentration 372 
dependent(58,59) which may explain the associations observed with suprathresholds in Dias et al. (8) 373 
but not with lower concentrations (STDT, STRT) used in this study. Nevertheless, the borderline 374 
non-significant trend observed for the TRPV1 rs8065080 may be detected in a larger sample size 375 
study. For such study to be clinically meaningful, in addition to salt taste perception, dietary salt 376 
intake should be measured, as acknowledged by Dias et al.(8). It has been shown that the reduction 377 
in salt intake results in important falls in BP, in both hypertensive and normotensive salt-sensitive 378 
individuals (2), and a reduction in overall CVD risk (1).  379 
 380 
4.2. Associations between salt sensitivity, salt taste perception and salt intake 381 
Together with the observed effect of genetics, salt sensitivity expressed as a change in BP 382 
after sodium loading was associated with taste thresholds for salt. In subjects that had complete 383 
dietary intervention data PP was positively associated with STDT. PP is the difference between 384 
SBP and DBP and is argued to be a better predictor of cardiovascular risk than SBP (60). PP may be 385 
genetically determined by the SLC4A5 rs7571842 (61). The mechanisms behind this association and 386 
the causality remain unknown. However, the hypothesis was that genetics may play a role in this 387 
relationship which aligns with the finding that this association was observed only in certain 388 
genotype groups of the SLC4A5 SNPs. This sub-group analysis should, nevertheless, be replicated 389 
in a study with a larger sample size in each genotype group, to achieve appropriate statistical power, 390 
and as such considered preliminary in this study. 391 
Sakamoto et al. (26) reported that the ENaC activity may be the link between salt taste 392 
sensitivity and salt sensitivity of BP in animals. However, the SCNN1B rs239345 was not 393 
associated with salt sensitivity or salt taste thresholds in this study. In a larger sample size study 394 
potential effect of interactions between the SLC4A5 and ENaC SNPs may be investigated and may 395 
provide insight into the mechanism behind this relationship. Nevertheless, the relevance of these 396 
findings lies in the actual relationship between salt taste thresholds and salt intake. 397 
If there is a positive association between the thresholds for salt and salt-sensitive changes in 398 
BP, it can be theorised that salt-sensitive individuals with higher thresholds are at greater risk of 399 
developing hypertension due to their higher salt intake. In the present study, however, neither 400 
detection nor the recognition threshold for salt have been associated with total habitual dietary salt 401 
intake. Nevertheless, discretionary salt use accounts for approximately 15% of salt intake in 402 
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Western countries (62) and the results of the present study suggest it may be associated with salt taste 403 
thresholds. The association between salt taste perception and discretionary salt use may depend on 404 
the SLC4A5 and TRPV1 genotype, however these sub-group analyses should be replicated in a 405 
larger size study. This would, nonetheless, be in line with the notion that reduced salt taste 406 
sensitivity (i.e. higher salt taste threshold) drives individuals to consume more salt until reaching the 407 
salt concentration identified as pleasant (14). Conversely, improved ability to taste salt when the taste 408 
of salt is deemed pleasant may result in increased salt intake. Indeed, research suggests that the 409 
preference for salty taste may be one of the factors affecting salt intake in younger populations and 410 
that discretionary salt use is more frequent in younger compared to older populations (63, 64). 411 
Moreover, when salt content of processed food is reduced, consumers compensate its apparent lack 412 
by increasing the discretionary salt use (65). Considering the evolving food supply and dietary habits 413 
of the UK population and worldwide, a better understanding of this behaviour could enable more 414 
targeted and effective public health interventions to reduce salt intake.  415 
 416 
4.3. Strengths and limitations  417 
This study has several strengths and limitations. A strength is the salt sensitivity 418 
phenotyping procedure with the dietary control of sodium intake. Moreover, a 24-hour ABPM 419 
procedure to determine the difference in BP between the diets provides many more measurements 420 
than conventional BP measurement reflecting usual BP more accurately. It also allows 421 
identification of individuals with a ‘white coat’ response or masked hypertension, and is a stronger 422 
predictor of cardiovascular morbidity and mortality than conventional measurement (34). One of the 423 
limitations is a use of a FFQ to determine dietary salt intake. Even though FFQ represents dietary 424 
intake over a longer time-period, it relies heavily on respondents’ honesty and long-term memory. 425 
However, sodium intake was energy adjusted, improving measurement accuracy. Freedman et al. 426 
(66) suggest that the attenuations and correlations with truth for the FFQs are improved when 427 
considering sodium densities, utilised in this study. Regarding the associations between genetics 428 
and variables of interest, where possible, a Cochran-Armitage test of trend was used. The advantage 429 
of the Cochran-Armitage trend test is that it is not dependent on the Hardy-Weinberg equilibrium 430 
assumption and is suggested as the genotype-based test for association (67-69). Finally, the small 431 
sample size in sub-group analyses of the correlations between salt taste perception, BP response to 432 
sodium loading and salt intake warrants replication of these results in a larger sample size study. 433 
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In conclusion, this preliminary data suggests there is a genetic predisposition to salt 434 
sensitivity in healthy, adult Caucasians. The SLC4A5 rs7571842 was confirmed as the variant with 435 
the effect on salt-sensitive changes in BP. Another SLC4A5 variant, rs10177833, most likely 436 
inherited together with the rs7571842, is associated with salt intake. Moreover, the observed 437 
associations between salt taste perception and salt sensitivity, together with the association between 438 
salt taste perception and discretionary salt use may depend on the SLC4A5 and TRPV1 genotype. 439 
Since there was no association between genetics and salt taste perception, the mechanisms behind 440 
these associations are to be further explored together with gene-gene interactions. Nevertheless, 441 
preference for salty taste may be a driver of salt intake in younger populations and warrants further 442 
investigation. Studies investigating these associations should comprehensively explore all potential 443 
variables, such as genetic predisposition, salt taste perception and salt intake to contribute towards 444 
more successful prevention of hypertension and CVD. 445 
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Tables 644 
Table 1. Baseline characteristics of study subjects, total sample (n=20) and according to salt 645 
sensitivity status (n=14). Data presented as mean and SEM or absolute (relative) frequencies. P 646 
value for difference between salt-sensitive and salt-resistant subjects (Independent samples t-test, 647 
Fischer’s exact test). 648 
 Total 
(n=20) 
Salt-sensitive 
(n=5) 
Salt-resistant 
(n=9) 
p 
Mean SEM Mean SEM Mean SEM 
Age (years) 28.0 (10.5)a) 35.8 4.6 33.2 2.7 0.612 
Sex        
Male 8 (40)  2 (40)  2 (22)  0.580 
Female 12 (60)  3 (60)  7 (78)  
Race        
White 16 (80)  4 (80 )  6 (67)  0.999 
Other 4 (20)  1 (20)  3 (33)  
BMI (kg/m2) 23.9 0.7 24.7 1.9 23.7 0.7 0.633 
SBP (mmHg) 121.3 3.0 125.8 9.2 118.2 4.4 0.413 
DBP (mmHg) 70.4 2.1 71.9 6.3 71.2 2.9 0.913 
Smoking 
status 
       
Yes 1 (5)  1 (20)  0  0.357 
No 19 (95)  4 (80)  9 (100)  
Physical 
activity level 
       
Active 15 (75)  2 (40)  7 (78)  0.413 
Moderately 
active 
1 (5)  1 (20)  0  
Moderately 
inactive 
2 (10)  1 (20)  1 (11)  
Inactive 2 (10)  1 (20)  1 (11)  
DBP, diastolic blood pressure; SBP, systolic blood pressure  649 
a), median (interquartile range) 650 
 651 
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Table 2. Clinical characteristics of study subjects (n=14) on low- and high-salt diet (mean and 652 
SEM). P values for difference between low- and high-salt diets (Paired samples t-test). 653 
 Low-salt diet High-salt diet p 
Mean SEM Mean SEM 
SBP (mmHg) 113.6 2.7 115.8 3.0 0.107 
DBP (mmHg) 66.9 1.4 68.6 2.2 0.261 
MAP (mmHg) 82.5 1.6 84.4 2.4 0.170 
PP (mmHg) 46.7 2.2 47.2 1.8 0.656 
Urine sodium excretion 
(mmol/24 hour) 
66.1 8.9 281.5 24.4 3.3 x 10-7 
Urine potassium 
excretion (mmol/24 
hour) 
75.8 5.5 81.8 5.8 0.243 
DBP, diastolic blood pressure; MAP, mean arterial pressure, PP, pulse pressure; SBP, systolic 654 
blood pressure 655 
 656 
 657 
 658 
 659 
 660 
 661 
 662 
 663 
 664 
 665 
 666 
 667 
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Table 3. Correlation analysis between salt taste thresholds (mol/l) and mean change in BP (mmHg) 668 
from low- to high-salt diet, and salt taste thresholds (mol/l) and dietary sodium intake (mg sodium 669 
per 1000 kcal) (n=14) 670 
 ∆SBP ∆DBP ∆MAP ∆PP Sodium intake  
STDT  0.098 (0.740) -0.377 (0.185) -0.303 (0.293) 0.551 (0.041) -0.016 (0.956) 
STRT  0.403 (0.153) 0.209 (0.473) 0.260 (0.370) 0.039 (0.895) -0.113 (0.700) 
DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; STDT, salt taste 671 
detection threshold; STRT, salt taste recognition threshold; SBP, systolic blood pressure 672 
Spearman rho (p value) 673 
 674 
 675 
 676 
 677 
 678 
 679 
 680 
 681 
 682 
 683 
 684 
 685 
 686 
 687 
 688 
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Figure legends 689 
 690 
Figure 1. Overview of the study procedure.  691 
Footnotes: ABPM, ambulatory blood pressure monitoring device; BP, blood pressure 692 
 693 
Figure 2. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure 694 
(MAP) change from low- to high-salt diet according to SLC4A5 rs7571842 (a) and rs10177833 (b) 695 
genotype status (n=14). Analysis conducted on the following model: major allele homozygote 696 
versus heterozygote plus minor allele homozygote. Error bars represent + SEM. (Independent 697 
samples t-test, *Mann-Whitney U test).  698 
Footnotes: DBP, diastolic blood pressure; MAP, mean arterial pressure; SBP, systolic blood 699 
pressure 700 
 701 
Figure 3. Proportion of subjects (n=20) with low and high salt taste recognition thresholds 702 
according to SLC4A5 rs7571842 (a) and rs10177833 (b), SCNN1B rs239345 (c) and TRPV1 703 
rs8065080 (d) genotype. Open bars represent low threshold and closed bars high threshold (Cochran 704 
Armitage test of trend).  705 
 706 
Figure 4. Proportion of subjects (n=20) in the different tertiles of energy adjusted sodium intake 707 
according to SLC4A5 rs7571842 (a) and rs10177833 (b), SCNN1B rs239345 (c) and TRPV1 708 
rs8065080 (d) genotype. Open bars represent first tertile (< 1241 mg/1000 kcal) and closed bars 709 
second + third tertile combined (≥ 1241 mg/1000 kcal) (Cochran Armitage test of trend). 710 
 711 
Figure 5. Correlation between salt taste thresholds and discretionary salt use according to SLC4A5 712 
rs7571842 (n=6) and TRPV1 rs8065080 (n=10) genotypes. Adding salt while cooking/table; 1-713 
always, 2-usually, 3-sometimes, 4-rarely, 5-never (Spearman’s correlation). 714 
 715 
